Skip To Main Content
Fangkai He on Muck Rack

Fangkai He

As seen in: Frontiers in Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fangkai

Contact Fangkai, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Integrated pharmacology and validation reveal Formononetin upregulates GSTM2 to modulate prostate cancer immune microenvironment via ROS/STAT3-driven chemokine reprogramming

|
By Tianlun Yu, Yu Zhou, Fangkai He, Yufan Wu, Shiyun Tang, Wei Qian, Zhouhan Zhu
| Frontiers in Immunology
Abstract Background: Prostate cancer (PCa) is responsible for a substantial proportion of male cancer cases worldwide. Biochemical recurrence (BCR) representing a critical challenge in its disease management. Formononetin, a natural isoflavone derived from traditional Chinese medicine, has demonstrated potential anticancer properties.
Open in Who Shared Issue with article?
See all 1 articles